Västra Hamnen Möter

Västra Hamnen Möter - Shape Robotics

Västra Hamnen Möter - Nexam Chemical Holding

Västra Hamnen Möter - SenzaGen

Västra Hamnen Möter - Spago Nanomedical

Västra Hamnen Möter - OptiCept Technologies

Västra Hamnen Möter - Precise Biometrics

Västra Hamnen Möter - Advenica

Västra Hamnen Möter - Xintela

Västra Hamnen Möter - Nasdaq

Västra Hamnen Möter - Arrow Lake

Västra Hamnen Möter - Clemondo Group

Västra Hamnen Möter - Neola Medical

Västra Hamnen Möter - BPC Instruments

Västra Hamnen Möter - Safeture

Transactions

BIMobject

Sydsvenska Hem

Qgroup

InCoax Networks

Transaktioner

CDON

Malmö stad

Ongoing transactions

Bolagsordning

ProstaLund

Videos

Pågående erbjudanden

Articles of association

ProstaLund: Från utmaning till möjlighet

ProstaLund: Nytt ledarskap efter turbulent höst

General meetings

ProstaLund: Hack i kurvan eller bestående trend?

ProstaLund: CoreTherm Eagle flygfärdig

Bolagsstämmor

Home

Completed transactions

Slutförda uppdrag

Finansiella rapporter

Financial reports

Analyser

Styrelse

Research updates

Board of Directors

ProstaLund presenterar Q4 2022

ProstaLund presenterar Q1 2022

Movinn presenterar Q1 2023

ProstaLund presenterar Q3 2021

BeammWave

Chordate presenterar på Investerardagen 2 december 2022

Chordate Medical presenterar Q4 2022

ProstaLund presents Q4 2022

Chordate Medical presents Q4 2022

Chordate Medical presents Q3 2022

Ledning

ProstaLund presenterar Q4 2021

ProstaLund presents Q2 2022

aXichem presenterar Q2 2023

Bioextrax

Qgroup presenterar på Investerardagen 9 juni 2022

Qlife presenterar på Investerardagen 2 december 2021

RugVista presenterar på Investerardagen 2 december 2021

SenzaGen presenterar på Investerardagen 2 december 2021

Iconovo

Speqta presenterar på Investerardagen 9 juni 2022

USWE presenterar på Investerardagen 8 juni 2021

Medimi presenterar Q1 2024

Chordate Medical presenterar Q2 2023

Chordate Medical presents Q2 2023

USWE presenterar Q2 2021/22

USWE presenterar Q3 2021/22

Movinn presenterar Q2 2023

Movinn presents Q2 2023

USWE presenterar Q4 2021/22

Chordate Medical presenterar Q1 2023

Chordate Medical presents Q1 2023

USWE presents Q1 2022/23

USWE Sports presenterar på Investerardagen 9 juni 2022

Crunchfish presents Q2 2023

Bioextrax kommenterar Q2 2024

CombiGene

Crunchfish presenterar Q2 2023

Crunchfish presents Q1 2023

Crunchfish presenterar Q1 2023

Medimi presenterar Q1 2023

Crunchfish presents Q3 2023

Medimi presents Q1 2023

ViroGates presenterar Q1 2022

Lime Technologies

Certified Adviser

ViroGates presenterar Q2 2021

Medimi presenterar Q2 2023

Cantargia

ViroGates presenterar Q3 2021

Medimi presents Q2 2023

ViroGates presenterar Q4 2021

Medimi presents Q2 2024

Medimi's CEO on the acquisition of MedThings

Services

About us

Contact

Here is more information about Västra Hamnen Corporate Finance's services.

Here you will find information about Västra Hamnen Corporate Finance's ongoing and completed transactions.

Here you will find more information about Västra Hamnen Corporate Finance.

Here, Västra Hamnen Corporate Finance's information for investors is gathered.

Investor relations

Västra Hamnen Corporate Finance

Commercialisation delays due to launch of UPI Lite X from NPCI

We have revised our valuation model and our financial forecast

We lower our fair value to SEK 12.70 (25.80) per share 

During the preceding quarter, the company achieved an important milestone by securing its first commercial deal in the Digital Cash business area with IDFC First Bank in India. However, the company has faced delays in the commercialisation process in connection with the introduction of UPI Lite X from NPCI. Revisions in our model have resulted in a fair value for the company of SEK 12.70 per share.

Crunchfish: Competition on the horizon

Crunchfish: Competition on the horizon

Download the report (pdf)

Filip Stenberg

Johan Larsson